Markets

Market Nav

News Details

28/01/2025 18:10

Tatva Chintan Pharm posts Q3 net loss of Rs 1.17 cr

The company reported standalone net loss during the quarter stood at Rs 1.17 crore compared to net profit of Rs 4.65 crore in the previous year quarter.ÿ

Net revenue of the company declined marginally by 2.41 per cent at Rs 84.00 crore in October-December quarter of this fiscal as against Rs 86.07 crore in the corresponding period last year.

During October-December quarter, operating expenses increased by 6.22 per cent to Rs 78.35 crore from Rs 73.76 crore in year ago period.

Other Income dipped by 96.69 per cent at Rs 0.04 crore versus (Dec'23 Rs 1.21 crore).

Operating Profit slipped by 54.10 per cent to Rs 5.65 crore as against Rs 12.31 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 53.04 per cent in December quarter.

Interest grew by 10.53 per cent y-o-y to Rs 0.42 crore, while Taxation decreased by 125.65 per cent at Rs -0.49 crore (Dec'23 Rs 1.91 crore).